<DOC>
	<DOCNO>NCT02349698</DOCNO>
	<brief_summary>The main purpose research verify safety CD19 target chimeric antigen receptor T cell determine proper dosage CAR T cell infuse .</brief_summary>
	<brief_title>A Clinical Research CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia Lymphoma</brief_title>
	<detailed_description>Nowadays refractory relapse leukemia/lymphoma lack effective treatment . Innovative therapy urgently require . Chimeric antigen receptor ( CAR ) -modified T cell demonstrate great success treat even late stage cluster differentiation antigen 19 ( CD19 ) positive B cell malignancy . To design good CAR T cell , develop new CD19 CARs . Preclinical study demonstrate effective kill CD19 target cell . In study , CD19 CARs , evaluate CD19 positive leukemia/lymphoma patient . The primary goal confirm adverse effect include cytokine storm response adverse effect . In addition , tumor target disease status treatment also evaluate .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<criteria>1 . Relapsed refractory B cell derive acute lymphoblastic leukemia ( ALL ) , chronic lymphocytic leukemia ( CLL ) nonhodgkin lymphoma . 2 . KPS &gt; 60 . 3 . Life expectancy &gt; 3 month . 4 . Gender unlimited , age 12 year 75 year . 5 . Disease progress reserve reaction recent treatment . 6 . Patients fail least one line standard treatment . 7 . No serious mental disorder . 8 . Patients must adequate cardiac function ( cardiac disease , LVEF≥40 % ) , adequate pulmonary function indicate room air oxygen saturation &gt; 94 % , adequate renal function ( Cr≤133umol/L ) . 9 . No serious disease ( autoimmune disease , immunodeficiency etc. ) . 10 . No tumor . 11 . Patients volunteer participate research . 1 . HIV affect . 2 . Patients allergic cytokine . 3 . Central nervous system leukemia within 28 day . 4 . Uncontrolled active infection . 5 . Acute chronic GVHD . 6 . Treated T cell inhibitor . 7 . Pregnancy nursing female . 8 . Other situation think improper research .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>CAR T</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
</DOC>